Meanwhile, SENP1 inhibitor Momordin Ιc (Mc) in combination with cisplatin has a synergistic effect on gastric tumor growth in vitro and in vivo.<h4>Conclusion</h4>SENP1 facilitates gastric cancer progression by metabolic reprogramming. This evidence concerns the gene SENP1 and gastric neoplasm.